Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Harley, L. Allan, H. Sanderson, P. Clarke (2010)
Phosphorylation of Mcl‐1 by CDK1–cyclin B1 initiates its Cdc20‐dependent destruction during mitotic arrestThe EMBO Journal, 29
G. Fang, Hongtao Yu, M. Kirschner (1998)
Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1.Molecular cell, 2 2
Grace Egan, S. Weitzman, S. Alexander (2019)
Burkitt Lymphoma and Diffuse Large B-Cell LymphomaNon-Hodgkin's Lymphoma in Childhood and Adolescence
L. Lindsey-Boltz, A. Sancar (2011)
Tethering DNA Damage Checkpoint Mediator Proteins Topoisomerase IIβ-binding Protein 1 (TopBP1) and Claspin to DNA Activates Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Phosphorylation of Checkpoint Kinase 1 (Chk1)*The Journal of Biological Chemistry, 286
(2007)
USP28 is a potential cancer drug target, as the deletion of Usp28 in a mouse model for colorectal cancer hindered tumor formation due to the stabilization of oncogenic proteins, such as c-Myc
Shimin Chen, Chun-ying Jiang, Jian‐Ying Wu, B. Liu, Ying-jian Chen, Chengjin Hu, Xian‐xi Liu (2010)
RNA interference‐mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivoClinical and Experimental Pharmacology and Physiology, 37
Amnon Golan, Y. Yudkovsky, A. Hershko (2002)
The Cyclin-Ubiquitin Ligase Activity of Cyclosome/APC Is Jointly Activated by Protein Kinases Cdk1-Cyclin B and Plk*The Journal of Biological Chemistry, 277
Sooyoung Lee, Woong Kim, Chunkyu Ko, W. Ryu (2016)
Hepatitis B virus X protein enhances Myc stability by inhibiting SCFSkp2 ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesisOncogene, 35
M. Gregory, S. Hann (2000)
c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma CellsMolecular and Cellular Biology, 20
M. Diefenbacher, N. Popov, Sophia Blake, Christina Schülein-Völk, E. Nye, B. Spencer‐Dene, L. Jaenicke, M. Eilers, A. Behrens (2014)
The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.The Journal of clinical investigation, 124 8
(2010)
promote MCL1 degradation, as do mechanisms independent of ubiquitin, highlighting the complexity, and indicating the importance, of MCL1 regulation
H. Strohmaier, C. Spruck, P. Kaiser, K. Won, O. Sangfelt, S. Reed (2001)
Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell lineNature, 413
A. Gerstein, T. Almeida, Guojing Zhao, Eric Chess, I. Shih, K. Buhler, K. Pienta, M. Rubin, R. Vessella, N. Papadopoulos (2002)
APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancersGenes, 34
A. Ougolkov, Bin Zhang, K. Yamashita, V. Bilim, M. Mai, S. Fuchs, T. Minamoto (2004)
Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer, 2003
Shahab Akhoondi, Dahui Sun, N. Lehr, S. Apostolidou, K. Klotz, Alena Maljukova, Diana Cepeda, H. Fiegl, D. Dafou, C. Marth, E. Mueller-Holzner, M. Corcoran, M. Dagnell, Sepideh Nejad, B. Nayer, M. Zali, J. Hansson, S. Egyhazi, F. Petersson, P. Sangfelt, H. Nordgren, D. Grandér, S. Reed, M. Widschwendter, O. Sangfelt, C. Spruck (2007)
FBXW7/hCDC4 is a general tumor suppressor in human cancer.Cancer research, 67 19
(2004)
F-box protein SKP2 is an APC/CCdh1 substrate and allows the CDKIs p27Kip1 and p21Cip1/Waf1 to accumulate (Figure 3) (Bashir et
T. Listovsky, Y. Oren, Y. Yudkovsky, H. Mahbubani, A. Weiss, M. Lebendiker, M. Brandeis (2004)
Mammalian Cdh1/Fzr mediates its own degradationThe EMBO Journal, 23
Jianping Jin, T. Shirogane, Lai Xu, G. Nalepa, G. Nalepa, J. Qin, S. Elledge, J. Harper (2003)
SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.Genes & development, 17 24
N. Lehr, S. Johansson, Siqin Wu, F. Bahram, A. Castell, Cihan Cetinkaya, P. Hydbring, Ingrid Weidung, K. Nakayama, K. Nakayama, O. Söderberg, T. Kerppola, L. Larsson (2003)
The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.Molecular cell, 11 5
Jeffrey Skaar, J. Pagan, M. Pagano (2013)
Mechanisms and function of substrate recruitment by F-box proteinsNature Reviews Molecular Cell Biology, 14
Norman Pavelka, Giulia Rancati, Rong Li (2010)
Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer.Current opinion in cell biology, 22 6
Shang-Ze Li, Yang Song, Hui-Hui Zhang, Bing-Xue Jin, Yi Liu, Wen-bin Liu, Xiao-Dong Zhang, Run-Lei Du (2014)
UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancerScientific Reports, 4
O. Timofeev, Onur Çizmecioğlu, E. Hu, Thomas Orlik, I. Hoffmann (2009)
Human Cdc25A phosphatase has a non‐redundant function in G2 phase by activating Cyclin A‐dependent kinasesFEBS Letters, 583
S. Malempati, Deanne Tibbitts, M. Cunningham, Y. Akkari, S. Olson, G. Fan, R. Sears (2006)
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemiasLeukemia, 20
M. Rapé, M. Kirschner (2004)
Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entryNature, 432
Page Am, Philip Hieter (1997)
The anaphase promoting complex.Cancer surveys, 29
M. Hollstein, D. Sidransky, B. Vogelstein, C. Harris (1991)
p53 mutations in human cancers.Science, 253 5015
(2004)
1999), promoting the transformed state. Such mutations are found in breast and colorectal cancers, to name a few (Rajagopalan et
Cun-Yu Wang, J. Cusack, Rong Liu, A. Baldwin (1999)
Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κBNature Medicine, 5
A. Peschiaroli, N. Dorrello, D. Guardavaccaro, M. Venere, T. Halazonetis, N. Sherman, M. Pagano (2006)
SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response.Molecular cell, 23 3
S. Geley, E. Kramer, C. Gieffers, J. Gannon, J. Peters, T. Hunt (2001)
Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis of Human Cyclin a Starts at the Beginning of Mitosis and Is Not Subject to the Spindle Assembly CheckpointThe Journal of Cell Biology, 153
C. Spruck, K. Won, S. Reed (1999)
Deregulated cyclin E induces chromosome instabilityNature, 401
Kai Wang, S. Yuen, Jiangchun Xu, Siu Lee, Helen Yan, S. Shi, H. Siu, Shibing Deng, K. Chu, S. Law, Kok Chan, Annie Chan, W. Tsui, S. Ho, Anthony Chan, Jonathan Man, Valentina Foglizzo, Man Ng, A. Chan, Y. Ching, Grace Cheng, T. Xie, Julio Fernández, V. Li, H. Clevers, P. Rejto, Mao Mao, S. Leung (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancerNature Genetics, 46
Jerry Hsu, J. Reimann, C. Sørensen, J. Lukas, P. Jackson (2002)
E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1Nature Cell Biology, 4
Liviu Malureanu, K. Jeganathan, F. Jin, D. Baker, J. Ree, Oliver Gullon, Zheyan Chen, J. Henley, J. Deursen (2010)
Cdc20 hypomorphic mice fail to counteract de novo synthesis of cyclin B1 in mitosisThe Journal of Cell Biology, 191
Hsiao-Chun Huang, Jue Shi, J. Orth, T. Mitchison (2009)
Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly.Cancer cell, 16 4
D. Engelbert, D. Schnerch, A. Baumgarten, R. Wäsch (2008)
The ubiquitin ligase APCCdh1 is required to maintain genome integrity in primary human cellsOncogene, 27
N. Popov, M. Wanzel, M. Madiredjo, D. Zhang, R. Beijersbergen, R. Bernards, R. Moll, S. Elledge, M. Eilers (2007)
The ubiquitin-specific protease USP28 is required for MYC stabilityNature Cell Biology, 9
D. Komander, M. Rapé (2012)
The ubiquitin code.Annual review of biochemistry, 81
(2004)
OTHER MAJOR SCF SUBSTRATES LINKED TO CANCER c-Myc c-Myc, a transcription factor that regulates cell proliferation and growth, is overexpressed in numerous hematological malignancies
Yingmeei Tan, O. Sangfelt, C. Spruck (2008)
The Fbxw7/hCdc4 tumor suppressor in human cancer.Cancer letters, 271 1
Lorenzo Lafranchi, H. Boer, Elisabeth Vries, Shao-En Ong, A. Sartori, Marcel Vugt (2014)
APC/CCdh1 controls CtIP stability during the cell cycle and in response to DNA damageThe EMBO Journal, 33
B. Thompson, S. Buonamici, M. Sulis, Teresa Palomero, T. Vilimas, G. Basso, A. Ferrando, I. Aifantis (2007)
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemiaThe Journal of Experimental Medicine, 204
A. Petitjean, E. Mathé, S. Kato, C. Ishioka, S. Tavtigian, P. Hainaut, M. Olivier (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 28
Qing Wang, C. Moyret-Lalle, Florence Couzon, Christine Surbiguet-Clippe, J. Saurin, T. Lorca, C. Navarro, A. Puisieux (2003)
Alterations of anaphase-promoting complex genes in human colon cancer cellsOncogene, 22
S. Kim, A. Herbst, Kathryn Tworkowski, S. Salghetti, W. Tansey (2003)
Skp2 regulates Myc protein stability and activity.Molecular cell, 11 5
Lili Wang, Xiaoyong Liu, E. Gusev, Chuanxin Wang, F. Fagotto (2014)
Regulation of the phosphorylation and nuclear import and export of &bgr;-catenin by APC and its cancer-related truncated formJournal of Cell Science, 127
Xi Yuan, J. Srividhya, Thomas Luca, Ju-hyong Lee, J. Pomerening (2014)
Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onsetMolecular Biology of the Cell, 25
E. Eytan, Kexi Wang, Shirly Miniowitz-Shemtov, Danielle Sitry-Shevah, S. Kaisari, T. Yen, Song-Tao Liu, A. Hershko (2014)
Disassembly of mitotic checkpoint complexes by the joint action of the AAA-ATPase TRIP13 and p31cometProceedings of the National Academy of Sciences, 111
H. Inuzuka, A. Tseng, Daming Gao, B. Zhai, Qing Zhang, S. Shaik, L. Wan, Xiaolu Ang, Caroline Mock, Haoqiang Yin, Haoqiang Yin, J. Stommel, S. Gygi, G. Lahav, J. Asara, Z. Xiao, W. Kaelin, J. Harper, Wenyi Wei (2010)
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.Cancer cell, 18 2
I. García-Higuera, Eusebio Manchado, P. Dubus, M. Cañamero, J. Méndez, S. Moreno, Marcos Malumbres (2008)
Genomic stability and tumour suppression by the APC/C cofactor Cdh1Nature Cell Biology, 10
C. Kraft, Franz Herzog, C. Gieffers, K. Mechtler, A. Hagting, J. Pines, J. Peters (2003)
Mitotic regulation of the human anaphase‐promoting complex by phosphorylationThe EMBO Journal, 22
J. Reimann, Bryan Gardner, Florence Margottin-Goguet, Peter Jackson (2001)
Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins.Genes & development, 15 24
(2003)
coactivator Cdh1 and the processivity factor Doc1
Katharine Sackton, Nevena Dimova, Xing Zeng, W. Tian, Mengmeng Zhang, Timothy Sackton, J. Meaders, Kathleen Pfaff, Frederic Sigoillot, Hongtao Yu, Xuelian Luo, R. King (2014)
Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/CNature, 514
(1986)
SCF-SKP2 and SCF-FBXW7 are two of at least three E3s that regulate the abundance of c-Myc (Kim et
D. Koepp, L. Schaefer, Xin Ye, K. Keyomarsi, C. Chu, J. Harper, S. Elledge (2001)
Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin LigaseScience, 294
E. Kramer, Nadja Scheuringer, A. Podtelejnikov, M. Mann, J. Peters (2000)
Mitotic regulation of the APC activator proteins CDC20 and CDH1.Molecular biology of the cell, 11 5
Yakir Moshe, J. Boulaire, M. Pagano, A. Hershko (2004)
Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.Proceedings of the National Academy of Sciences of the United States of America, 101 21
M. Gstaiger, R. Jordan, Megan Lim, C. Catzavelos, J. Mestan, J. Slingerland, W. Krek (2001)
Skp2 is oncogenic and overexpressed in human cancersProceedings of the National Academy of Sciences of the United States of America, 98
Chang‐Min Kim, K. Koike, I. Saito, T. Miyamura, G. Jay (1991)
HBx gene of hepatitis B virus induces liver cancer in transgenic miceNature, 351
Peter Bailey, D. Chang, K. Nones, A. Johns, A. Patch, M. Gingras, David Miller, Angelika Christ, T. Bruxner, M. Quinn, C. Nourse, L. Murtaugh, Ivon Harliwong, S. Idrisoglu, Suzanne Manning, Ehsan Nourbakhsh, Shivangi Wani, L. Fink, O. Holmes, V. Chin, M. Anderson, S. Kazakoff, C. Leonard, F. Newell, N. Waddell, S. Wood, Qinying Xu, P. Wilson, N. Cloonan, K. Kassahn, Darrin Taylor, Kelly Quek, Alan Robertson, L. Pantano, Laura Mincarelli, L. Sánchez, Lisa Evers, Jianmin Wu, M. Pinese, M. Cowley, Marc Jones, E. Colvin, A. Nagrial, Emily Humphrey, L. Chantrill, A. Mawson, J. Humphris, A. Chou, M. Pajic, C. Scarlett, Andreia Pinho, Marc Giry-Laterrière, I. Rooman, J. Samra, J. Kench, Jessica Lovell, N. Merrett, C. Toon, K. Epari, N. Nguyen, A. Barbour, N. Zeps, Kim Moran-Jones, N. Jamieson, J. Graham, F. Duthie, K. Oien, J. Hair, R. Grützmann, A. Maitra, C. Iacobuzio-Donahue, elliot fishman, R. Morgan, R. Lawlor, V. Corbo, C. Bassi, B. Rusev, P. Capelli, R. Salvia, G. Tortora, D. Mukhopadhyay, G. Petersen, D. Munzy, W. Fisher, Saadia Karim, J. Eshleman, R. Hruban, C. Pilarsky, J. Morton, O. Sansom, A. Scarpa, E. Musgrove, Ulla-Maja Bailey, Oliver Hofmann, R. Sutherland, D. Wheeler, A. Gill, R. Gibbs, J. Pearson, N. Waddell, A. Biankin, S. Grimmond (2016)
Genomic analyses identify molecular subtypes of pancreatic cancerNature, 531
Paul Clute, J. Pines (1999)
Temporal and spatial control of cyclin B1 destruction in metaphaseNature Cell Biology, 1
M. Berlingieri, P. Pallante, A. Sboner, M. Barbareschi, M. Bianco, A. Ferraro, G. Mansueto, E. Borbone, E. Guerriero, G. Troncone, A. Fusco (2007)
UbcH10 is overexpressed in malignant breast carcinomas.European journal of cancer, 43 18
Leifu Chang, Ziguo Zhang, Jing Yang, S. McLaughlin, D. Barford (2014)
Molecular architecture and mechanism of the anaphase-promoting complexNature, 513
L. Passmore, E. Mccormack, S. Au, A. Paul, K. Willison, J. Harper, D. Barford (2003)
Doc1 mediates the activity of the anaphase‐promoting complex by contributing to substrate recognitionThe EMBO Journal, 22
E. Bolesta, L. Pfannenstiel, A. Demelash, M. Lesniewski, M. Tobin, S. Schlanger, Shreeram Nallar, J. Papadimitriou, D. Kalvakolanu, B. Gastman (2012)
Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy ResistanceMolecular and Cellular Biology, 32
P. Fonseca, E. Kong, Ziguo Zhang, Anne Schreiber, Mark Williams, E. Morris, D. Barford (2010)
Structures of APC/CCdh1 with substrates identify Cdh1 and Apc10 as the D-box co-receptorNature, 470
Christopher Carroll, M. Enquist-Newman, D. Morgan (2005)
The APC Subunit Doc1 Promotes Recognition of the Substrate Destruction BoxCurrent Biology, 15
S. Kaisari, Danielle Sitry-Shevah, Shirly Miniowitz-Shemtov, A. Hershko (2016)
Intermediates in the assembly of mitotic checkpoint complexes and their role in the regulation of the anaphase-promoting complexProceedings of the National Academy of Sciences, 113
Cun-Yu Wang, M. Mayo, A. Baldwin (1996)
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 274
I. Mamely, M. Vugt, V. Smits, J. Semple, B. Lemmens, A. Perrakis, R. Medema, R. Freire (2006)
Polo-like Kinase-1 Controls Proteasome-Dependent Degradation of Claspin during Checkpoint RecoveryCurrent Biology, 16
Min Li, Xiao Fang, Pumin Zhang (2009)
Loss of spindle assembly checkpoint–mediated inhibition of Cdc20 promotes tumorigenesis in miceThe Journal of Cell Biology, 185
S. Shieh, Jinwoo Ahn, K. Tamai, Y. Taya, C. Prives (2000)
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.Genes & development, 14 3
Chia-Hsin Chan, J. Morrow, Chien-Feng Li, Yuan Gao, G. Jin, A. Moten, Loren Stagg, J. Ladbury, Zhenxin Cai, Dazhi Xu, C. Logothetis, M. Hung, Shuxing Zhang, Hui-Kuan Lin (2013)
Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer ProgressionCell, 154
(2013)
Electron microscopy structure of human APC/C CDH1 -EMI1 reveals multimodal mechanism of E3 ligase shutdown
Wei Li, M. Bengtson, Axel Ulbrich, A. Matsuda, V. Reddy, A. Orth, S. Chanda, S. Batalov, C. Joazeiro (2008)
Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle's Dynamics and SignalingPLoS ONE, 3
Zengquan Wang, M. Boudjelal, Sewon Kang, J. Voorhees, G. Fisher (1999)
Erratum: Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment (Nature Medicine (1999) 5 (418-422))Nature Medicine, 5
K. Alexander, P. Hinds (2001)
Requirement for p27KIP1 in Retinoblastoma Protein-Mediated SenescenceMolecular and Cellular Biology, 21
I. Wertz, Saritha Kusam, Cynthia Lam, T. Okamoto, W. Sandoval, Daniel Anderson, Elizabeth Helgason, J. Ernst, M. Eby, Jinfeng Liu, L. Belmont, J. Kaminker, K. O’Rourke, Kanan Pujara, P. Kohli, Adam Johnson, M. Chiu, J. Lill, P. Jackson, W. Fairbrother, S. Seshagiri, M. Ludlam, K. Leong, E. Dueber, H. Maecker, D. Huang, V. Dixit (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7Nature, 471
F. Bahram, N. Lehr, Cihan Cetinkaya, L. Larsson (2000)
c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover.Blood, 95 6
Hongling Zhao, F. Bauzon, H. Fu, Zhonglei Lu, Jinhua Cui, Kei-ichi Nakayama, K. Nakayama, J. Locker, Liang Zhu (2013)
Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressors.Cancer cell, 24 5
Bettina Buschhorn, G. Petzold, M. Gálová, P. Dube, C. Kraft, Franz Herzog, H. Stark, J. Peters (2010)
Substrate binding on the APC/C occurs between the co-activator CDH1 and the processivity factor DOC1Nature structural & molecular biology, 18
M. Donzelli, M. Squatrito, D. Ganoth, A. Hershko, M. Pagano, G. Draetta (2002)
Dual mode of degradation of Cdc25 A phosphataseThe EMBO Journal, 21
Wenyi Wei, N. Ayad, Y. Wan, Guo‐Jun Zhang, M. Kirschner, W. Kaelin (2004)
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complexNature, 428
N. Watanabe, H. Arai, Yoshifumi Nishihara, M. Taniguchi, N. Watanabe, T. Hunter, H. Osada (2004)
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.Proceedings of the National Academy of Sciences of the United States of America, 101 13
K. Won, S. Reed (1996)
Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E.The EMBO Journal, 15
(2007)
N.A.B. is supported by an Australian Research Council Future Fellowship (FT110100223)
H. Rajagopalan, P. Jallepalli, C. Rago, V. Velculescu, K. Kinzler, B. Vogelstein, C. Lengauer (2004)
Inactivation of hCDC4 can cause chromosomal instabilityNature, 428
A. Minella, K. Loeb, Andrea Knecht, M. Welcker, B. Varnum‐Finney, I. Bernstein, James Roberts, B. Clurman (2008)
Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo.Genes & development, 22 12
M. Frost, J. Newell, M. Lones, S. Tripp, M. Cairo, S. Perkins (2004)
Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.American journal of clinical pathology, 121 3
Shirly Miniowitz-Shemtov, E. Eytan, S. Kaisari, Danielle Sitry-Shevah, A. Hershko (2015)
Mode of interaction of TRIP13 AAA-ATPase with the Mad2-binding protein p31comet and with mitotic checkpoint complexesProceedings of the National Academy of Sciences, 112
H. Fukushima, K. Ogura, L. Wan, Ying Lu, V. Li, Daming Gao, Pengda Liu, Alan Lau, Tao Wu, M. Kirschner, H. Inuzuka, Wenyi Wei (2013)
SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression.Cell reports, 4 4
Daniela Brito, C. Rieder (2006)
Mitotic Checkpoint Slippage in Humans Occurs via Cyclin B Destruction in the Presence of an Active CheckpointCurrent Biology, 16
N. Lehman, E. Verschuren, Jerry Hsu, A. Cherry, P. Jackson (2006)
Overexpression of the Anaphase Promoting Complex/Cyclosome Inhibitor Emi1 Leads to Tetraploidy and Genomic Instability of p53-Deficient CellsCell Cycle, 5
Chang Kim, Jae Song, Y. Cho, Y. Kim, S. Kim, S. Nam, N. Yoo, Jung Lee, W. Park (2007)
Somatic mutations of the β‐TrCP gene in gastric cancerAPMIS, 115
Hermann-Josef Meyer, M. Rapé (2014)
Enhanced Protein Degradation by Branched Ubiquitin ChainsCell, 157
T. Bashir, N. Dorrello, V. Amador, D. Guardavaccaro, M. Pagano (2004)
Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligaseNature, 428
Yuchi Honaker, H. Piwnica-Worms (2010)
Casein Kinase 1 Functions as both Penultimate and Ultimate Kinase in Regulating Cdc25A DestructionOncogene, 29
R. Buttyan, I. Sawczuk, M. Benson, J. Siegal, C. Olsson (1988)
Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancersThe Prostate, 11
J. Roberts, D. Allison, R. Donehower, E. Rowinsky (1990)
Development of polyploidization in taxol-resistant human leukemia cells in vitro.Cancer research, 50 3
F. Bassermann, David Frescas, D. Guardavaccaro, L. Busino, A. Peschiaroli, M. Pagano (2008)
The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response CheckpointCell, 134
(2004)
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradationProceedings of the National Academy of Sciences of the United States of America, 101
(1999)
A–CDK2 and cyclin
Reinhard Sigl, Cornelia Wandke, V. Rauch, J. Kirk, T. Hunt, S. Geley (2009)
Loss of the mammalian APC/C activator FZR1 shortens G1 and lengthens S phase but has little effect on exit from mitosisJournal of Cell Science, 122
I. Onoyama, R. Tsunematsu, Akinobu Matsumoto, Taichi Kimura, I. Alborán, Kei-ichi Nakayama, K. Nakayama (2007)
Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesisThe Journal of Experimental Medicine, 204
M. Garnett, J. Mansfeld, Colin Godwin, T. Matsusaka, Jiahua Wu, P. Russell, J. Pines, A. Venkitaraman (2009)
UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exitNature cell biology, 11
D. Guardavaccaro, Y. Kudo, J. Boulaire, M. Barchi, L. Busino, M. Donzelli, F. Margottin-Goguet, P. Jackson, L. Yamasaki, M. Pagano (2003)
Control of Meiotic and Mitotic Progression by the F Box Protein β-Trcp1 In VivoDevelopmental Cell, 4
L. Busino, M. Donzelli, Massimo Chiesa, D. Guardavaccaro, D. Ganoth, N. Dorrello, A. Hershko, M. Pagano, G. Draetta (2003)
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damageNature, 426
H. Inuzuka, S. Shaik, I. Onoyama, Daming Gao, A. Tseng, R. Maser, B. Zhai, L. Wan, A. Gutierrez, Alan Lau, Yonghong Xiao, A. Christie, J. Aster, J. Settleman, S. Gygi, A. Kung, T. Look, K. Nakayama, R. DePinho, Wenyi Wei (2011)
SCFFBW 7 regulates cellular apoptosis by targeting MCL 1 for ubiquitylation and destruction
M. Warr, Stéphane Acoca, Zhiqian Liu, M. Germain, M. Watson, M. Blanchette, S. Wing, G. Shore (2005)
BH3‐ligand regulates access of MCL‐1 to its E3 ligaseFEBS Letters, 579
J. Ree, K. Jeganathan, Liviu Malureanu, J. Deursen (2010)
Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formationThe Journal of Cell Biology, 188
W. Chao, K. Kulkarni, Ziguo Zhang, E. Kong, D. Barford (2012)
Structure of the mitotic checkpoint complexNature, 484
Jianping Jin, T. Cardozo, R. Lovering, S. Elledge, M. Pagano, J. Harper (2004)
Systematic analysis and nomenclature of mammalian F-box proteins.Genes & development, 18 21
M. Welcker, J. Singer, K. Loeb, Jonathan Grim, A. Bloecher, Mark Gurien-West, B. Clurman, James Roberts (2003)
Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation.Molecular cell, 12 2
F. Margottin-Goguet, Jerry Hsu, A. Loktev, H. Hsieh, J. Reimann, P. Jackson (2003)
Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase.Developmental cell, 4 6
E. Eytan, Danielle Sitry-Shevah, Adar Teichner, A. Hershko (2013)
Roles of different pools of the mitotic checkpoint complex and the mechanisms of their disassemblyProceedings of the National Academy of Sciences, 110
Q. Ding, Xianghuo He, J. Hsu, W. Xia, Chun-Te Chen, L. Li, Dung-Fang Lee, Jaw-Ching Liu, Q. Zhong, Xiaodong Wang, M. Hung (2006)
Degradation of Mcl-1 by β-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and ChemosensitizationMolecular and Cellular Biology, 27
Vivian Li, S. Ng, P. Boersema, T. Low, W. Karthaus, Jan. Gerlach, S. Mohammed, A. Heck, M. Maurice, T. Mahmoudi, H. Clevers (2012)
Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 ComplexCell, 149
Julie Miller, M. Summers, David Hansen, M. Nachury, N. Lehman, A. Loktev, P. Jackson (2006)
Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.Genes & development, 20 17
Q. Zhong, Wenhua Gao, Fenghe Du, Xiaodong Wang (2005)
Mule/ARF-BP1, a BH3-Only E3 Ubiquitin Ligase, Catalyzes the Polyubiquitination of Mcl-1 and Regulates ApoptosisCell, 121
A. Hagting, N. Elzen, Hartmut Vodermaier, I. Waizenegger, J. Peters, J. Pines (2002)
Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1The Journal of Cell Biology, 157
Christina Schülein-Völk, E. Wolf, Jing Zhu, Wenshan Xu, Lyudmyla Taranets, Andreas Hellmann, L. Jänicke, M. Diefenbacher, A. Behrens, M. Eilers, N. Popov (2014)
Dual regulation of Fbw7 function and oncogenic transformation by Usp28.Cell reports, 9 3
Yoshinori Kanemori, K. Uto, N. Sagata (2005)
Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.Proceedings of the National Academy of Sciences of the United States of America, 102 18
W. Zachariae, M. Schwab, K. Nasmyth, W. Seufert (1998)
Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex.Science, 282 5394
Peng Ji, Hong Jiang, Katya Rekhtman, Joanna Bloom, Marina Ichetovkin, M. Pagano, Liang Zhu (2004)
An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.Molecular cell, 16 1
M. Matsumoto, K. Wickliffe, K. Dong, Christine Yu, I. Bosanac, Daisy Bustos, Lilian Phu, D. Kirkpatrick, S. Hymowitz, M. Rapé, R. Kelley, V. Dixit (2010)
K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody.Molecular cell, 39 3
W. Fleming, A. Hamel, R. Macdonald, Ernest Ramsey, N. Pettigrew, B. Johnston, J. Dodd, R. Matusik (1986)
Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia.Cancer research, 46 3
M. Yada, S. Hatakeyama, T. Kamura, Masaaki Nishiyama, R. Tsunematsu, Hiroyuki Imaki, N. Ishida, F. Okumura, Kei-ichi Nakayama, K. Nakayama (2004)
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7The EMBO Journal, 23
Hongbo Wang, F. Bauzon, Peng Ji, X. Xu, Daqian Sun, J. Locker, R. Sellers, Kei-ichi Nakayama, K. Nakayama, D. Cobrinik, Liang Zhu (2010)
Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/− miceNature Genetics, 42
(2011)
SCFFBW7 regulates cellular apoptosis
Christopher Sistrunk, Sun Kim, Xian Wang, Sung Lee, Yongbaek Kim, Everardo Macias, M. Rodriguez-Puebla (2013)
Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation.The American journal of pathology, 182 5
S. Matsuoka, Y. Oike, I. Onoyama, A. Iwama, F. Arai, K. Takubo, Y. Mashimo, H. Oguro, E. Nitta, Keisuke Ito, K. Miyamoto, Hiroki Yoshiwara, Kentaro Hosokawa, Yuka Nakamura, Yumiko Gomei, H. Iwasaki, Y. Hayashi, Y. Matsuzaki, K. Nakayama, Y. Ikeda, A. Hata, S. Chiba, K. Nakayama, T. Suda (2008)
Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.Genes & development, 22 8
M. Matyskiela, D. Morgan (2009)
Analysis of activator-binding sites on the APC/C supports a cooperative substrate-binding mechanism.Molecular cell, 34 1
Niels Mailand, Simon Bekker-Jensen, J. Bartek, J. Lukas (2006)
Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress.Molecular cell, 23 3
F. Wolf, Cornelia Wandke, N. Isenberg, S. Geley (2006)
Dose‐dependent effects of stable cyclin B1 on progression through mitosis in human cellsThe EMBO Journal, 25
(2009)
Tumor evasion is likely linked to the extent
T. Saitoh, Masaru Katoh (2001)
Expression profiles of betaTRCP1 and betaTRCP2, and mutation analysis of betaTRCP2 in gastric cancer.International journal of oncology, 18 5
A. Koch, A. Waha, W. Hartmann, Aksana Hrychyk, U. Schüller, A. Waha, K. Wharton, S. Fuchs, D. Schweinitz, T. Pietsch (2005)
Elevated Expression of Wnt Antagonists Is a Common Event in HepatoblastomasClinical Cancer Research, 11
A. Kumagai, Joon Lee, H. Yoo, W. Dunphy (2006)
TopBP1 Activates the ATR-ATRIP ComplexCell, 124
S. Salghetti, So Kim, W. Tansey (1999)
Destruction of Myc by ubiquitin‐mediated proteolysis: cancer‐associated and transforming mutations stabilize MycThe EMBO Journal, 18
T. Sudo, M. Nitta, H. Saya, N. Ueno (2004)
Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly CheckpointCancer Research, 64
Jianghuai Liu, Suresh Kg, Duonan Yu, S. Molton, Martin McMahon, M. Herlyn, A. Thomas-Tikhonenko, Serge Fuchs (2007)
Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cellsOncogene, 26
B. Clurman, R. Sheaff, Kenneth Thress, M. Groudine, James Roberts (1996)
Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.Genes & development, 10 16
M. Donzelli, Luca Busini, Massimo Chiesa, D. Ganoth, A. Hershko, G. Draetta (2004)
Hierarchical order of phosphorylation events commits Cdc25A to Beta-TrCP-dependent degradationCell Cycle, 3
J. Reimann, E. Freed, Jerry Hsu, E. Kramer, J. Peters, P. Jackson (2001)
Emi1 Is a Mitotic Regulator that Interacts with Cdc20 and Inhibits the Anaphase Promoting ComplexCell, 105
Lingyan Jin, Adam Williamson, Sudeep Banerjee, Isabelle Philipp, M. Rapé (2008)
Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting ComplexCell, 133
Zhan Xiao, Zehan Chen, A. Gunasekera, T. Sowin, S. Rosenberg, S. Fesik, Haiying Zhang (2003)
Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents*Journal of Biological Chemistry, 278
Hui-Kuan Lin, Zhenbang Chen, Guocan Wang, C. Nardella, Szu-Wei Lee, Chan-Hsin Chan, Wei-Lei Yang, Jing Wang, Ainara Egia, K. Nakayama, C. Cordon-Cardo, J. Teruya-Feldstein, P. Pandolfi (2010)
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceNature, 464
S. Jaspersen, J. Charles, D. Morgan (1999)
Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14Current Biology, 9
Tao Wu, Y. Merbl, Ying Huo, J. Gallop, Amit Tzur, M. Kirschner (2010)
UBE2S drives elongation of K11-linked ubiquitin chains by the Anaphase-Promoting ComplexProceedings of the National Academy of Sciences, 107
T. Sudo, Yosuke Ota, S. Kotani, M. Nakao, Y. Takami, S. Takeda, H. Saya (2001)
Activation of Cdh1‐dependent APC is required for G1 cell cycle arrest and DNA damage‐induced G2 checkpoint in vertebrate cellsThe EMBO Journal, 20
(2010)
In conjunction with Ube2S, the APC/C can assemble branched chains containing blocks of Lys11 linkages that improve proteasomal signaling capacity
Adam Williamson, K. Wickliffe, B. Mellone, Ling Song, G. Karpen, M. Rapé (2009)
Identification of a physiological E2 module for the human anaphase-promoting complexProceedings of the National Academy of Sciences, 106
J. Leverson, Haichao Zhang, Jiangtao Chen, S. Tahir, D. Phillips, John Xue, Paul Nimmer, Sha Jin, Monica Smith, Yu Xiao, P. Kovar, A. Tanaka, Bruncko Milan, G. Sheppard, Lu Wang, S. Gierke, L. Kategaya, Daniel Anderson, Chihunt Wong, J. Eastham‐Anderson, M. Ludlam, D. Sampath, W. Fairbrother, I. Wertz, S. Rosenberg, Chris Tse, S. Elmore, A. Souers (2015)
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)Cell Death & Disease, 6
Dong Zhang, K. Zaugg, T. Mak, S. Elledge (2006)
A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage ResponseCell, 126
C. Greil, J. Krohs, D. Schnerch, M. Follo, J. Felthaus, M. Engelhardt, R. Wäsch (2016)
The role of APC/CCdh1 in replication stress and origin of genomic instabilityOncogene, 35
(1998)
SKP2 overexpression is often correlated with the reduced expression of p27Kip1 and a poor prognosis in several advanced human cancers
Zhiwei Wang, H. Inuzuka, Jiateng Zhong, H. Fukushima, L. Wan, Pengda Liu, Wenyi Wei (2012)
DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destructionOncotarget, 3
Weiping Wang, M. Kirschner (2013)
Emi1 preferentially inhibits ubiquitin chain elongation by the anaphase promoting complexNature cell biology, 15
Ulrich Binné, M. Classon, F. Dick, Wenyi Wei, M. Rapé, W. Kaelin, A. Näär, N. Dyson (2007)
Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exitNature Cell Biology, 9
Christopher Carroll, D. Morgan (2002)
The Doc1 subunit is a processivity factor for the anaphase-promoting complexNature Cell Biology, 4
M. Erlanson, Cajsa Portin, B. Linderholm, J. Lindh, G. Roos, G. Landberg (1998)
Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications.Blood, 92 3
David Hansen, A. Loktev, Kenneth Ban, P. Jackson (2004)
Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.Molecular biology of the cell, 15 12
S. Müerköster, A. Arlt, B. Sipos, M. Witt, M. Grossmann, G. Klöppel, H. Kalthoff, U. Fölsch, H. Schäfer (2005)
Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.Cancer research, 65 4
S. Chuang, P. Yeh, Yen-Shen Lu, G. Lai, C. Liao, M. Gao, A. Cheng (2002)
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.Biochemical pharmacology, 63 9
Uncontrolled cell proliferation and genomic instability are common features of cancer and can arise from, respectively, the loss of cell-cycle control and defective checkpoints. Ubiquitin-mediated proteolysis, ultimately executed by ubiquitin-ligating enzymes (E3s), plays a key part in cell-cycle regulation and is dominated by two multisubunit E3s, the anaphase-promoting complex (or cyclosome) (APC/C) and SKP1–cullin-1–F-box (SCF) complex. We highlight the role of APC/C and the SCF bound to F-box proteins, FBXW7, SKP2, and β-TrCP, in regulating the abundance of select fundamental proteins, primarily during the cell cycle, that are associated with human cancer. The clinical success of the first proteasome inhibitor, bortezomib, in treating multiple myeloma and mantle-cell lymphoma set the precedent for viewing the ubiquitin–proteasome system as a druggable target for cancer. Given that there are more E3s than kinases, selective, small-molecule E3 inhibitors have the potential of opening up another dimension in the therapeutic armamentarium for the treatment of cancer.
Annual Review of Cancer Biology – Annual Reviews
Published: Mar 6, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.